Forte Biosciences (FBRX) Free Cash Flow (2016 - 2020)
Historic Free Cash Flow for Forte Biosciences (FBRX) over the last 5 years, with Q4 2020 value amounting to -$3.8 million.
- Forte Biosciences' Free Cash Flow fell 41253.37% to -$3.8 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$18.4 million, marking a year-over-year decrease of 52812.82%. This contributed to the annual value of -$30.8 million for FY2024, which is 690.42% down from last year.
- According to the latest figures from Q4 2020, Forte Biosciences' Free Cash Flow is -$3.8 million, which was down 41253.37% from -$7.7 million recorded in Q3 2020.
- In the past 5 years, Forte Biosciences' Free Cash Flow registered a high of $16.0 million during Q2 2019, and its lowest value of -$17.8 million during Q1 2019.
- Moreover, its 5-year median value for Free Cash Flow was -$7.5 million (2017), whereas its average is -$6.0 million.
- Its Free Cash Flow has fluctuated over the past 5 years, first soared by 24004.38% in 2019, then plummeted by 199729.0% in 2020.
- Forte Biosciences' Free Cash Flow (Quarter) stood at -$7.8 million in 2016, then dropped by 22.33% to -$9.5 million in 2017, then crashed by 30.82% to -$12.4 million in 2018, then surged by 94.02% to -$742000.0 in 2019, then plummeted by 412.53% to -$3.8 million in 2020.
- Its Free Cash Flow was -$3.8 million in Q4 2020, compared to -$7.7 million in Q3 2020 and -$4.0 million in Q2 2020.